Evidence map›Paper›PMID 33671849›Full record

ArticleCells2021

Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study.

Nazlisadat Seyed Khoei, Robert Carreras-Torres, Neil Murphy, Marc J Gunter, Paul Brennan, Karl Smith-Byrne, Daniela Mariosa, James Mckay, Tracy A O'Mara, Ruth Jarrett and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. An interpretable machine learning model for preoperative prediction of renal mass malignancy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Gilbert's syndrome: The good, the bad and the ugly.World journal of hepatology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 9 countries.

Nazlisadat Seyed KhoeiDepartment of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6003-7794
Robert Carreras-TorresColorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 8908 Barcelona, Spain.ORCID 0000-0002-2925-734X
Neil MurphyNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Marc J GunterNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Paul BrennanGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Karl Smith-ByrneGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Daniela MariosaGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
James MckayGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Tracy A O'MaraDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane 4006, Queensland, Australia.
Ruth JarrettInstitute of Infection, Immunity and Inflammation, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.ORCID 0000-0003-0390-3478
Henrik HjalgrimDepartment of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen, Denmark.
Karin E SmedbyDepartment of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Wendy CozenDepartments of Preventive Medicine and Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.
Kenan OnelDepartment of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 60637, USA.
Arjan DiepstraDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0001-9239-1050
Karl-Heinz WagnerDepartment of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1683-7265
Heinz FreislingNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0001-8648-4998
Centre international de recherche sur le cancer · FRUniversity of Vienna · ATBellvitge University Hospital · ESIcahn School of Medicine at Mount Sinai · USKarolinska University Hospital · SEMRC University of Glasgow Centre for Virus Research · GBQIMR Berghofer Medical Research Institute · AUStatens Serum Institut · DKUniversity Medical Center Groningen · NLUniversity of Southern California · US

Funding

Austrian Science Fund FWF P 29608Medical Research Council MC_UU_12014/3World Health Organization 001
6 · The paper itself

Abstract

Bilirubin, an endogenous antioxidant, may play a protective role in cancer development. We applied two-sample Mendelian randomization to investigate whether genetically raised bilirubin levels are causally associated with the risk of ten cancers (pancreas, kidney, endometrium, ovary, breast, prostate, lung, Hodgkin's lymphoma, melanoma, and neuroblastoma). The number of cases and their matched controls of European descent ranged from 122,977 and 105,974 for breast cancer to 1200 and 6417 for Hodgkin's lymphoma, respectively. A total of 115 single-nucleotide polymorphisms (SNPs) associated (

Indexed as

Mendelian Randomization AnalysisBilirubinBiomarkersBreast NeoplasmsGenome-Wide Association StudyHumansPolymorphism, Single NucleotideRisk FactorsBilirubinBiomarkersbilirubincancer riskMendelian randomizationUGT1A1

Identifiers

PMID33671849
PMCPMC7918902
OpenAlexW3130886014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.